Berna Kosekaya

Dr. Berna Kosekaya is a regulatory strategist with over a decade of hands-on experience in drug development, regulatory science and health authority interactions across global markets. Currently, at Novo Nordisk, she works on end-to-end regulatory strategies, guiding programs from early clinical stages all the way to approvals in the US, EU, UK and Asia-Pacific. With a background that includes both regulatory agency and industry roles, she brings a practical, big-picture approach to navigating complex submissions. Berna is also an honorary lecturer at King’s College London and an active contributor in international regulatory forums, where she focuses on bridging science, policy and people. She trained as a pharmacist and holds a PhD in Pharmacology.